In its report, the WHO team agreed that the concept of RISUG was intriguing. But they found fault with the homegrown production methods: Guha and his staff made the concoction themselves in his lab, and the WHO delegation found his facilities wanting by modern pharmaceutical manufacturing standards. Furthermore, they found that Guha’s studies did not meet “international regulatory requirements” for new drug approval—certain data was missing. The final recommendation: WHO should pass on RISUG.
Is this an example of why health care is so incredibly expensive in this country?
Do these "modern pharmaceutical manufacturing standards" actually buy us extra safety?
Is this an example of why health care is so incredibly expensive in this country?
Do these "modern pharmaceutical manufacturing standards" actually buy us extra safety?